 |
|
|
|
Year 2007 - Volume 27, Number 11
|
|
Technological development of (40mg) furosemide tablets: a equivalence and bioavaibility study in dogs, p.462-466
|
ABSTRACT.- Lima E.Q., Albuquerque M.M., Rodrigues O.G., Alencar J.R.B., Medeiros F.P.M. & Neto P.R. 2007. Technological development of (40mg) furosemide tablets: a equivalence and bioavaibility study in dogs. Pesquisa Veterinária Brasileira 27(11):462.466. Unidade Acadêmica de Medicina Veterinária (UAMV), Centro de Saúde e Tecnologia Rural (CSTR), Universidade Federal de Campina Grande (UFCG), Av. Acadêmica s/n, Santa Cecília, Cx. Postal 64, Patos, PB 58708110, Brazil. E-mail: onaldo@cstr.ufcg.edu.br
Furosemide (40mg) was administered to 20 street dogs, 10 males and 10 females, in two different pharmaceutical forms: (1) compressed furosemide 40mg formulated at the Federal University of Pernambuco (UFPE-tablet), and (2) a commercial formulation with equal bioequivalence produced by the Laboratory for Pharmaceutical Technology of Pernambuco State (LAFEPE), the LAFEPE-furosemide. The study aimed to evaluate the kinetics of dissolution of the UFPE-tablet in order to analyze the behavior of bioavailability of the best formulation for veterinary use. The plasmatic concentrations of furosemide for the determination of parameters of pharmacological kinetics were analyzed by high-performance liquid chromato-graphic method (HPLC). The in vitro study accomplished through physiochemical analyses demonstrated that the formulas of the furosemide tablets attained the pharmaceutical requirements in agreement with USP 23 and the Brazilian Pharmacopoeia. The evaluation accomplished in dogs with UFPE-tablets given in only dose demonstrated uniformity in blood levels indicating stability in maintenance of the pharmaceutical formulation and efficiency in absorption of the active compound. These values are not significantly different in relation to the 5% confidence limit. Regarding maximum concentration (Tmax) time and global bioavaibility assessed by AUC means, there were no considerable differences as well. UFPE-furosemide displayed 743.492µg/mL.h as AUC average value whereas LAFEPE-furosemide had an average of 537.284µg/mL.h. |
| |
|
|
| |
|
|
